Cancer Patients First-ever Acute Ischemic Stroke Clinical Trial
Official title:
A Pilot Trial of Enoxaparin Versus Aspirin in Patients With Cancer and Stroke
Patients with cancer who develop stroke are at high risk for future strokes or other clotting
events. These patients are routinely treated with medicines that thin their blood, including
enoxaparin or aspirin. However, it is unclear which medicine is best and whether these
medicines can be adequately studied in a clinical trial.
The purpose of this Phase I/II study is to determine if a clinical trial of different blood
thinners in patients with cancer and stroke is possible. In addition, the study aims to
compare the effects, good and/or bad, of enoxaparin with those of aspirin on patients with
cancer and recent stroke.
n/a